Symposium:
43. Tuberculosis: What's New in Diagnosis and Management
Thursday, October 4, 2018: 10:30 AM-11:45 AM
Room: S 214-216

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the management of both HIV+ and HIV- persons with tuberculosis
  • discuss the complications of tuberculosis therapy and drivers of multi-drug resistant Mycobacterium tuberculosis
  • explain diagnostic modalities for tuberculosis, both latent and active forms

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists

Tracks: Trainee, Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID


Moderators:  Wesley Van Voorhis, MD PhD, University of Washington and Christina Coyle, MD, Albert Einstein College of Medicine

Presentations:
10:30 AM
146
10:55 AM
147
Management of TB in HIV-infected patients
Graeme Meintjes, MBChB, FCP, MRCP, MPH, PhD

11:20 AM
148
Testing Diagnostics for TB
David Alland, MD

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-205-L01-P

Disclosures:

W. Van Voorhis, None

C. Coyle, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.